Status:
UNKNOWN
Prognostic Impact of Anatomical Resection Vs. Non-anatomical Resection for HCC
Lead Sponsor:
University of Milan
Conditions:
Patients Affected by Hepatocellular Carcinoma
Disease-Free Survival
Eligibility:
All Genders
Phase:
NA
Brief Summary
Prognostic impact of AR vs NAR
Detailed Description
Whether anatomical is better than non anatomical resection for HCC is still debated. This prospective randomized study aimed to address which approach is better in terms of patients prognosis.
Eligibility Criteria
Inclusion
- patient affected by single HCC
- patients in whom liver resection is indicated
- HCC without vascular invasion and/or thrombosis
Exclusion
- multinodular HCC
- metastatic disease
- spontaneous tumor rupture
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2017
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01236989
Start Date
January 1 2011
End Date
December 1 2017
Last Update
November 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Istituto Clinico Humanitas
Rozzano, Milan, Italy, 20089